Washington Manual of Medical Therapeutics
- Vaccine-preventable diseases [table]
- Vaginitis
- Vaginosis
- Valproic acid
- Valsalva [table]
- Valsartan [table]
- Valsartanan [table]
- Vancomycin intermediate-resistant Saureus (VISA)
- Vancomycin-resistant Enterococcus faecium (VRE)
- Variceal bleeding
- Variceal ligation/banding
- Varicella-zoster virus
- Vasodilator therapy
- Vasoocclusive complications (VOCs)
- Venous thromboembolic disorders
- Ventilation-perfusion (V/Q) mismatch
- Ventilation-perfusion (V/Q) scan
- Ventricular fibrillation (VF)
- Ventricular pseudoaneurysm
- Ventricular septal rupture
- Venturi masks
- Verapamil SR [table]
- Vertebrobasilar strokes
- Viability testing
- Vibrio vulnificus
- Vilanterol [table]
- Viral enteritis
- Viral hemorrhagic fever [table]
- Viral meningitis [table]
- Viral protease
- Visceral sarcoma
- Vitamin A [table]
- Vitamin B₁ [table]
- Vitamin B₁₂
- Vitamin B₁₂ deficiency
- Vitamin B₃ [table]
- Vitamin B₅ [table]
- Vitamin B₆ [table]
- Vitamin B₇ [table]
- Vitamin B₉ [table]
- Vitamin C [table]
- Vitamin E [table]
- Vitamin K deficiency
- Vitamin K replacement, bleeding, liver disease
- Vocal cord dysfunction (VCD)
- Voclosporin
- Voglibose [table]
- Volume control (VC)
- Volume deficits
- Voxelotor
- Vulvovaginal candidiasis
- vWF plasma-derived concentrate transfusions